Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion (including some of the leading FDA-approved cell and gene therapy medicines).

As cell and gene therapies continue to make headlines as a key opportunity for growth, success in this field will require both innovative tech as well as strategic foresight.

As cell and gene therapy grows rapidly, life sciences manufacturers will soon encounter new challenges, including a fundamental shift from ‘made-to-stock’ to ‘made-to-order', says Bryan ...

Bayer will use the platform to provide support to its cell and gene therapy businesses and orchestrate its operations in the area across the product life cycle.

Where some gene therapy players might “go big” and put down brick and mortar facilities, Avrobio went the opposite direction. | Cell and gene therapies are already revolutionizing treatment ...

Recommendations The development of cell and gene therapies calls for a standard application of risk management principles in line with the current guidelines for product development.

The Regulatory Affairs for Cell and Gene Therapy post-baccalaureate certificate program trains leaders for this growing discipline and prepares them to bring new therapeutics to market. Students learn ...

Bharat Biotech is pumping $75 million into a new cell and therapy manufacturing facility at the Indian drugmaker’s facility located in what is known as Genome Vally in Hyderabad.

Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using ...

Cell and gene therapy research has been hot the past few years but the overall market has cooled down in recent months. During the World Medical Innovation Forum in Boston, a panel of venture ...